Risk of swallowing-related chest infections in patients with nasopharyngeal carcinoma treated with definitive intensity-modulated radiotherapy.

about

Risk of swallowing-related chest infections in patients with nasopharyngeal carcinoma treated with definitive intensity-modulated radiotherapy.

Item

http://www.wikidata.org/entity/Q38739241

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年論文

@yue

2016年論文

@zh-hant

2016年論文

@zh-hk

2016年論文

@zh-mo

2016年論文

@zh-tw

2016年论文

@wuu

2016年论文

@zh

2016年论文

@zh-cn

name

Risk of swallowing-related che ...... ensity-modulated radiotherapy.

@en

type

Item

label

Risk of swallowing-related che ...... ensity-modulated radiotherapy.

@en

prefLabel

Risk of swallowing-related che ...... ensity-modulated radiotherapy.

@en

P1476

Risk of swallowing-related che ...... ensity-modulated radiotherapy.

@en

P2093

Andrea Lay Hoon Kwa

http://www.w3.org/2001/XMLSchema#string

Chwee Ming Lim

http://www.w3.org/2001/XMLSchema#string

Gita Krishnaswamy

http://www.w3.org/2001/XMLSchema#string

Jiaqing Xiong

http://www.w3.org/2001/XMLSchema#string

Kwok Seng Loh

http://www.w3.org/2001/XMLSchema#string

Sharon Raynor

http://www.w3.org/2001/XMLSchema#string

P2860

Dysphagia disorders in patients with cancer of the oropharynx are significantly affected by the radiation therapy dose to the superior and middle constrictor muscle: a dose-effect relationship.

Assessing quality of life in patients with head and neck cancer: cross-validation of the European Organization for Research and Treatment of Cancer (EORTC) Quality of Life Head and Neck module (QLQ-H&N35).

Aspiration pneumonia after chemo-intensity-modulated radiation therapy of oropharyngeal carcinoma and its clinical and dysphagia-related predictors.

Intensity-modulated radiotherapy of head and neck cancer aiming to reduce dysphagia: early dose-effect relationships for the swallowing structures.

Dysphagia following chemoradiation for locally advanced head and neck cancer.

Phase III study of radiation therapy with or without cis-platinum in patients with unresectable squamous or undifferentiated carcinoma of the head and neck: an intergroup trial of the Eastern Cooperative Oncology Group (E2382).

Evaluation of early and late toxicities in chemoradiation trials.

Factors associated with severe late toxicity after concurrent chemoradiation for locally advanced head and neck cancer: an RTOG analysis

Aspiration in chemoradiated patients with head and neck cancer.

Practical considerations in the re-irradiation of recurrent and second primary head-and-neck cancer: who, why, how, and how much?

P304

E1660-5

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/HED.24296

http://www.w3.org/2001/XMLSchema#string

P478

38 Suppl 1

http://www.w3.org/2001/XMLSchema#string

P577

2016-02-18T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

26891064

http://www.w3.org/2001/XMLSchema#string

P921

swallowing